Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial

INTRODUCTION: Acute coronary syndrome (ACS) is one of the leading causes of morbidity and mortality worldwide. Secondary cardiovascular risk reduction therapy (consisting of an aspirin, a β-blocker, an ACE inhibitor or an angiotensin II receptor blocker and a statin) is needed for all patients with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open
Glavni autori: Zidan, Amani, Awaisu, Ahmed, Kheir, Nadir, Mahfoud, Ziyad, Kaddoura, Rasha, AlYafei, Sumaya, El Hajj, Maguy Saffouh
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2016
Teme:
Health Services Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129077/
https://ncbi.nlm.nih.gov/pubmed/27864247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-012141
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items